Back

dr. A.J.A.T. (Arthur) Braat

dr. A.J.A.T. (Arthur) Braat

Associate Professor

Show full profile

Research Output (111)

Personalized Dosimetry:The Way to Limit Hepatotoxicity

Braat Manon N G J A, Braat Arthur J A T, Lam Marnix G E H Mar 2020, In: Journal of Vascular and Interventional Radiology. 31 , p. 515-516 2 p.

Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer REPLY:Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer REPLY

van Kalmthout Ludwig W M, van Melick Harm E, Lavalaye Jules, Meijer Richard P, Kooistra Anko, de Klerk John M H, Braat Arthur J A T, Kaldeway H Peter, de Bruin P C, de Keizer Bart, Lam Marnix G E H Mar 2020, In: The Journal of Urology. 203 , p. 545-545 1 p.

177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)

Braat A., Van Rooij R., Bruijnen Rutger, Braat M., Wessels F., van Leeuwaarde R., van Treijen M., de Jong H., Lam M. Mar 2020, In: Neuroendocrinology. 110 , p. 249-249

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS):a single-centre, single-arm, open-label, phase 2 study

Braat Arthur J A T, Bruijnen Rutger C G, van Rooij Rob, Braat Manon N G J A, Wessels Frank J, van Leeuwaarde Rachel S, van Treijen Mark J C, de Herder Wouter W, Hofland Johannes, Tesselaar Margot E T, de Jong Hugo W A M, Lam Marnix G E H 26 Feb 2020, In: LANCET ONCOLOGY. 21 , p. 561-570 10 p.

The Dutch recommendation for Treatment of Pediatric Differentiated Thyroid Carcinoma

Lebbink Chantal, Dekker Bernadette L, Bocca Gianni, Braat Arthur, Derikx Joep P. M., Dierselhuis Miranda, de Keizer B, Kruijff Schelto, Kwast A. B.G., van Nederveen Francien H, van Dijkum Els J. Nieveen, Nievelstein Rutger A. J., Peeters Robin P, Terwisscha van Scheltinga Sheila, Tissing Wim, van der Tuin Karin, Vriens Menno, van Trotsenburg A. S. Paul, Links Thera P, van Santen HM 23 Feb 2020, 1 p.

Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases:study protocol for a multicenter, randomized controlled trial (LUTIA trial)

Ebbers Sander C, Braat Arthur J A T, Moelker Adriaan, Stokkel Marcel P M, Lam Marnix G E H, Barentsz Maarten W 5 Feb 2020, In: Trials. 21 , p. 1-9

Radioembolization with Y-90 Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy

Braat A J A T, Ahmadzadehfar H, Kappadath S C, Stothers C L, Frilling A, Deroose C M, Flamen P, Brown D B, Sze D Y, Mahvash A, Lam M G E H 1 Feb 2020, In: Cardiovascular and Interventional Radiology. 43 , p. 246-253 8 p.

Radioembolization

van Roekel Caren, Braat Arthur J.A.T., Smits Maarten L.J., Bruijnen Rutger C.G., de Keizer Bart, Lam Marnix G.E.H. 1 Jan 2020, p. 961-999 39 p.

Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study

van Roekel Caren, van den Hoven Andor F., Bastiaannet Remco, Bruijnen Rutger C.G., Braat Arthur J.A.T., de Keizer Bart, Lam Marnix G.E.H., Smits Maarten L.J. 2020, In: European Journal of Nuclear Medicine and Molecular Imaging. 48 , p. 1658-1668 11 p.

Clinical feasibility of quantitative holmium-166 SPECT in presence of technetium-99m colloid

Stella M, Braat Arthur, Lam Marnix, de Jong Hugo, van Rooij Rob 2020,

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not